Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Cencora (COR)

Cencora agrees to buy American Oncology Network at $2.4 billion enterprise value

Mixed Impact 5 of 5 m&a

Cencora signed a merger agreement to acquire American Oncology Network (AON), valuing AON at an enterprise value of $2.4 billion, including $2.3 billion at closing and up to $100 million in contingent value rights. The same day, Cencora said its fiscal 2026 adjusted diluted EPS is now expected to be at least $17.90, at the high end of its prior $17.75 to $17.95 range, and that the deal is expected to be accretive to adjusted diluted EPS in the second year after closing.

Key points

  • Enterprise value of $2.4 billion: $2.3 billion at closing plus up to $100 million in CVRs
  • Cencora expects to pay about $1.7 billion to raise its AON stake to 75%, assuming holders keep up to 25% through an equity rollover
  • Fiscal 2026 adjusted diluted EPS now expected to be at least $17.90, the high end of the prior $17.75 to $17.95 range
  • Fiscal 2027 expectations to be discussed on the fourth quarter fiscal 2026 earnings call on November 4, 2026

The filing

CompanyCencora (COR)
Form8-K, current report
Filed with the SECOct 21, 2026, 7:48 AM ET
Accession number0001104659-26-117576

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.